BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4406591)

  • 1. The effects of calcitonin on the metabolic disturbances surrounding widespread bony metastases.
    Parsons V; Dalley V; Brinkley D; Davies C; Vernon A
    Acta Endocrinol (Copenh); 1974 Jun; 76(2):286-301. PubMed ID: 4406591
    [No Abstract]   [Full Text] [Related]  

  • 2. Salmon calcitonin in the treatment of bone metastases.
    SerdengeƧti S; SerdengeƧti K; Derman U; Berkarda B
    Int J Clin Pharmacol Res; 1986; 6(2):151-5. PubMed ID: 3721646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast carcinoma.
    Ditzel J; Jordal R; Riskaer N
    Acta Endocrinol (Copenh); 1968 Nov; 59(3):353-61. PubMed ID: 5754976
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in patients with bone neoplasms.
    Radom S; Zulawski M; Golebiowska D
    Pol Med J; 1972; 11(4):809-14. PubMed ID: 4342776
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of synthetic salmon calcitonin in the treatment of bone lesions of the neoplastic type].
    Adamo V; Altavilla G; La Torre F; Palmara D; Tropea F
    Tumori; 1982 Feb; 68(1):63-6. PubMed ID: 7071947
    [No Abstract]   [Full Text] [Related]  

  • 6. [Synthetic salmon calcitonin in the therapeutic management of osteolytic metastases of breast carcinoma].
    Simone C; Racanelli A
    Clin Ter; 1981 Aug; 98(3):247-67. PubMed ID: 7285537
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of calcitonin and hexestrol on urinary excretion of hydroxyproline in a patient with prostatic cancer and bone metastases.
    Matsushita Y; Hasegawa K; Sugimura R; Otomo S; Morii H
    Endocrinol Jpn; 1974 Apr; 21(2):109-13. PubMed ID: 4408206
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone collagen and calcium metabolism in normocalcemic and hypercalcemic patients with breast cancer.
    Lee CA; Lloyd HM
    Cancer; 1971 May; 27(5):1099-105. PubMed ID: 5092517
    [No Abstract]   [Full Text] [Related]  

  • 9. [Skeletal metastasis from lung and breast neoplasms].
    Marini G; Leoni V
    Quad Radiol; 1968; 33(5):455-66. PubMed ID: 5737117
    [No Abstract]   [Full Text] [Related]  

  • 10. [OSSEOUS METASTASES OF BRONCHO-PULMONARY NEOPLASMS].
    CAVALLO V; LUCHERINI M
    Policlinico Prat; 1964 Jun; 71():993-9. PubMed ID: 14174160
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of calcitonin in metastatic bone carcinoma, osteoporosis, polyostotic fibrous dysplasia and hypercalcemia.
    Morii H; Tanae A; Ibayashi H; Nakao K
    Endocrinol Jpn; 1971 Feb; 17(6):81-90. PubMed ID: 4254451
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary hydroxyproline and plasma mucoprotein as an indication of the presence of bone metastases.
    Basu TK; Donaldson D; Williams DC
    Oncology; 1974; 30(3):197-203. PubMed ID: 4459734
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of bone loss by hormone replacement therapy is probably not due to stimulation of calcitonin secretion.
    Fletcher CD; Farish E; Leggate J; Hart DM
    Acta Endocrinol (Copenh); 1991 Apr; 124(4):353-6. PubMed ID: 2031433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urine hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in neoplastic diseases].
    Radom S; Zulawski M; Golebiowska D
    Nowotwory; 1971; 21(4):267-73. PubMed ID: 5138713
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of synthetic salmon calcitonin in patients with Paget's disease of bone.
    Hamilton CR
    Am J Med; 1974 Mar; 56(3):315-22. PubMed ID: 4855941
    [No Abstract]   [Full Text] [Related]  

  • 16. The clinical physiology of calcium homeostasis, parathyroid hormone, and calcitonin. II.
    Kleeman CR; Massry SG; Coburn JW
    Calif Med; 1971 Apr; 114(4):19-30. PubMed ID: 4927915
    [No Abstract]   [Full Text] [Related]  

  • 17. [Letter: Prednisone treatment of breast cancer with metastases].
    Billund JK
    Ugeskr Laeger; 1974 Jun; 136(24):1306. PubMed ID: 4840262
    [No Abstract]   [Full Text] [Related]  

  • 18. The acute response to calcitonin in Paget's disease: its relationship to the serum alkaline phosphatase level and the effect of phosphate treatment.
    Gershberg H; Girgis M; Goldberg L; Duga J; St Paul H
    J Clin Endocrinol Metab; 1973 Apr; 36(4):691-6. PubMed ID: 4686375
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bone metastases of primary bronchial cancer].
    Cabanel G; Voog R; Phelip X; Riondel J
    Rev Rhum Mal Osteoartic; 1969 May; 36(5):229-41. PubMed ID: 5402865
    [No Abstract]   [Full Text] [Related]  

  • 20. Is calcitonin a helper of phosphate binders in the control of renal osteodystrophy?
    Ionova D; Zlatarska S; Kirjakov Z
    Nephrol Dial Transplant; 1995; 10(9):1782. PubMed ID: 8559512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.